Vitamin D plays a key role in skeletal and cardiovascular disorders, cancers, central nervous
system diseases, reproductive diseases, infections, and autoimmune and dermatological …

Psoriasis is a systemic, chronic, immune-mediated disease that affects approximately 2–3%
of the world's population. The etiology and pathophysiology of psoriasis are still unknown …

Background Long‐term therapy for psoriasis is impaired by gradual loss of effectiveness and
treatment discontinuation. Identifying factors that affect biologic drug survival may help in …

Little information is available from real-life studies evaluating the efficacy of guselkumab in
moderate-to-severe psoriasis. In this real-life study, we retrospectively examined a database …

A great deal of research has addressed the elevation of C‐reactive protein (CRP) among
psoriatic patients and the role of this marker in assessment of disease severity and …

Background Obesity is a leading comorbidity in psoriatic disease, including both psoriasis
(PsO) and psoriatic arthritis (PsA), and is associated with adverse metabolic and …

Background There are few data on the prevalence of obesity in the general psoriasis
population and on the real impact of obesity on the management of psoriasis patients in the …

Obesity is a significant burden on global healthcare due to its high prevalence and
associations with chronic health conditions. In our animal studies, ongoing exposure to low …

Background: Vitamin D has been shown to have immunomodulatory effects, and previous
studies have proposed a role of vitamin D deficiency in multiple autoimmune diseases …

Psoriasis has been related to metabolic syndrome (MS). Adipocytokines produced by white
adipose tissue may be involved in the pathogenesis of psoriasis and its association with MS …